The U.S. Federals are seeking about $1 billion from Johnson & Johnson (NYSE:JNJ) to resolve a long running investigation. The Federal Government has been investigating Johnson & Johnson’s Janssen Pharmaceutica since 2004, and whether or not they have been promoting the drug Risperdal for unapproved uses. it is alleged that J&J used false marketing to [...]